Código QR

B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer

Aleksander Kielbik,1– 3 Veronika Bahlinger,3,4 Christian M Schürch,3,4 Maria Luisa Barcena,2 Olesya Vakhrusheva,2 Anita Thomas,5 Igor Tsaur,2 Jonas S Heitmann,1,3 Helmut R Salih,1,3,6 Ilona Hagelstein1,3,6 1Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, Univer...

Descrición completa

Gardado en:
Principais autores: Kielbik A, Bahlinger V, Schürch CM, Barcena ML, Vakhrusheva O, Thomas A, Tsaur I, Heitmann JS, Salih HR, Hagelstein I
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2026-05-01
Series:ImmunoTargets and Therapy
Assuntos:
penile cancer
bispecific antibody
immunotherapy
CD3
B7-H3
CD276
Acceso en liña:https://www.dovepress.com/b7-h3-cd276-as-target-for-t-cell-based-bispecific-antibody-therapy-of--peer-reviewed-fulltext-article-ITT
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares